Richard T. Kenney

Insider Reports History

Location
C/O Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle, WA
Signature
/s/ Richard T. Kenney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard T. Kenney:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sonnet BioTherapeutics Holdings, Inc. Chief Medical Officer Common Stock 9.37K $12.5K $1.33 Jul 11, 2025 Direct
Sonnet BioTherapeutics Holdings, Inc. Chief Medical Officer Warrant 320K Jul 14, 2025 Direct
Sonnet BioTherapeutics Holdings, Inc. Chief Medical Officer Series 5 Preferred Stock 200 Jul 14, 2025 Direct

Insider Reports Filed by Richard T. Kenney

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SONN Sonnet BioTherapeutics Holdings, Inc. Jul 11, 2025 1 $0 4 Jul 15, 2025 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Jun 30, 2025 3 $0 4 Aug 21, 2025 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 11, 2023 1 $0 4 Dec 5, 2024 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Jan 7, 2023 2 $0 4 Feb 17, 2023 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 14, 2022 1 $0 4 Dec 22, 2022 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. Jun 9, 2021 1 $23.1K 4 Jun 9, 2021 Chief Medical Officer
SONN Sonnet BioTherapeutics Holdings, Inc. May 19, 2021 1 $15.5K 4 May 20, 2021 Chief Medical Officer